Skip to content

13F-HR filed by ORACLE INVESTMENT MANAGEMENT INC

ORACLE INVESTMENT MANAGEMENT INC filed this 13F-HR for the quarter ended 2014-12-31, filed 2015-02-17, with 28 holding rows worth $762,619,000.

Accession
0001085146-15-000735
Filed
2015-02-17
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2014

A holdings report, 28 entries on the cover page, a total value of $762,619,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $762,619,000 with VALUE read as thousands by filing date, 13F file number 028-05592. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ACCELR8 TECHNOLOGY INC004304200COM5,425,893$104,123,000thousands by filing date
QUIDEL CORP74838J101COM2,915,633$84,320,000thousands by filing date
NXSTAGE MEDICAL INC67072V103COMMON STOCK3,754,343$67,315,000thousands by filing date
TENET HEALTHCARE CORP88033G100COMMON STOCK1,292,392$65,486,000thousands by filing date
OPKO HEALTH INC68375N103COM5,258,886$52,522,000thousands by filing date
ACORDA THERAPEUTICS INC00484M106COM1,032,700$42,206,000thousands by filing date
THORATEC CORP885175307COM1,232,600$40,010,000thousands by filing date
CHIMERIX INC COM16934W106Stock969,400$39,028,000thousands by filing date
Transition Therapeutics, Inc.893716209COM4,861,321$33,237,000thousands by filing date
ACCURAY INC DEL004397105COM3,657,700$27,616,000thousands by filing date
BIOLASE INC090911108COMMON STOCK10,474,725$27,486,000thousands by filing date
MAZOR ROBOTICS LTD57886P103SPONSORED ADS2,125,000$26,371,000thousands by filing date
PACIFIC BIOSCIENCES CALIF INC COM69404D108Stock3,230,518$25,327,000thousands by filing date
TESARO INC881569107COM556,379$20,692,000thousands by filing date
RAPTOR PHARMACEUTICAL CORP75382F106COM1,942,892$20,439,000thousands by filing date
VERMILLION INC92407M206COM NEW8,112,182$16,114,000thousands by filing date
HANSEN MEDICAL INC411307101COM26,027,981$14,466,000thousands by filing date
INTREXON CORP46122T102COM368,500$10,145,000thousands by filing date
WEBMD HEALTH CORP94770V102COM238,103$9,417,000thousands by filing date
PLASMATECH BIOPHARMACEUTICAL72754H109COM2,686,895$9,270,000thousands by filing date
CERUS CORP157085101COM1,018,505$6,355,000thousands by filing date
AMARIN CORP PLC023111206SPONS ADR NEW5,181,444$5,076,000thousands by filing date
AGENUS INC00847G101COM1,161,134$4,610,000thousands by filing date
SECOND SIGHT MED PRODS INC81362J100COM431,582$4,428,000thousands by filing date
METABOLIX INC591018809COM8,000,000$3,280,000thousands by filing date
BIOGEN INC COM09062X103Stock7,723$2,622,000thousands by filing date
LADENBURG THALMANN FINANCIAL50575Q102COM111,789$442,000thousands by filing date
LEXICON PHARMACEUTICALS INC528872104COM237,077$216,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001085146-15-000735this filing2015-02-17acceptance time not in the bulk data set